BEAM vs CHPT · rev $63.5M vs rev $417.1M
Beam Therapeutics Inc (BEAM) versus ChargePoint Holdings Inc (CHPT) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
ChargePoint Holdings Inc (CHPT) is a specialty retail company listed on NYSE.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported CHPT revenue for 2025-01-31 was $417.1M. Net income was -$277.1M. Revenue was down 17.7% from 2024-01-31 to 2025-01-31. CHPT currently screens at market cap $199.2M.
BEAM currently screens at market cap $2.01B. CHPT currently screens at market cap $199.2M.
Not investment advice. Open the BEAM and CHPT stock pages for the full models.
Not investment advice.